New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alpha Teknova, Inc.
TKNO
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

291M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

291M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

5.45USD
Shape0.62 ( 12.84%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-83%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 12, 2024
1W 12.60 % 1M 23.86 % 3M 325.78 % 1Y 175.25 %

Key Metrics

Shape
  • Market Cap

    290.50M


  • Shares Outstanding

    53.30M


  • Share in Float

    10.62M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    5.45


  • Average Volume

    630917


  • Beta

    0.435


  • Range

    1.155-5.4699


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.teknova.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.99x

P/S Ratio

2.71x

P/B Ratio

0.2

Debt/Equity

-98.1%

Net Margin

$-0.9

EPS

How TKNO compares to sector?

P/E Ratio

Relative Strength

Shape

TKNO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$43M

Shape344%

2025-Revenue

$0.42

Shape-227%

2025-EPS

$7M

Shape-40%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

KeyBanc

initialise

Previous: Not converted

2023-07-12

Now: Sector Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.21
vs -0.12

Q4.22

arrow
arrow

N/A

-0.47
vs -0.13

Q1.23

arrow
arrow

N/A

-0.31
vs -0.20

Q2.23

arrow
arrow

N/A

-0.25
vs -0.22

Q3.23

arrow
arrow

N/A

-0.34
vs -0.21

Q4.23

arrow
arrow

N/A

-0.22
vs -0.47

Q1.24

arrow
arrow

N/A

-0.20
vs -0.31

Q2.24

arrow
arrow

N/A

-0.13
vs -0.25

Q3.24

arrow
arrow

N/A

-0.11
vs -0.34

Q4.24

arrow
arrow

N/A

-0.12
vs -0.22

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+14%

10.7M  vs 9.4M

Q4.22

arrow
arrow

-22%

7.9M  vs 10.1M

Q1.23

arrow
arrow

-18%

9.1M  vs 11.1M

Q2.23

arrow
arrow

-1%

11.5M  vs 11.7M

Q3.23

arrow
arrow

-24%

8.2M  vs 10.7M

Q4.23

arrow
arrow

0%

7.9M  vs 7.9M

Q1.24

arrow
arrow

+2%

9.3M  vs 9.1M

Q2.24

arrow
arrow

-17%

9.6M  vs 11.5M

Q3.24

arrow
arrow

+12%

9.2M  vs 8.2M

Q4.24

arrow
arrow

+15%

9M  vs 7.9M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-20%

-0.20
vs -0.05

Q4.22

arrow
arrow

-13%

-0.13
vs -0.20

Q1.23

arrow
arrow

-10%

-0.10
vs -0.13

Q2.23

arrow
arrow

-8%

-0.08
vs -0.10

Q3.23

arrow
arrow

-10%

-0.10
vs -0.08

Q4.23

arrow
arrow

-12%

-0.12
vs -0.10

Q1.24

arrow
arrow

-10%

-0.10
vs -0.12

Q2.24

arrow
arrow

-7%

-0.07
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

49

49
vs 49

NA

Q4.22

arrow
arrow

45

45
vs 49

-8%

Q1.23

arrow
arrow

43

43
vs 45

-4%

Q2.23

arrow
arrow

29

29
vs 43

-33%

Q3.23

arrow
arrow

27

27
vs 29

-7%

Q4.23

arrow
arrow

30

30
vs 27

11%

Q1.24

arrow
arrow

30

30
vs 30

NA

Q2.24

arrow
arrow

27

27
vs 30

-10%

Earnings Growth

Latest News